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Alzheimer’s disease (AD) is the most prevalent cause of dementia, that represents
one of the major health challenges for humanity, with significant social and economic
implications. This complex and progressive neurodegenerative disorder is characterized
by specific molecular hallmarks, as amyloid beta deposition and neurofibrillary tau
tangles. The etiology of this disease is far from being fully understood, and the possibility
of an infectious cause has long been debated.
Even Alois Alzheimer, himself, over 100 years ago studied Treponema pallidum, the
causative agent of syphilis, a spirochete later associated with dementia (Noguchi and
Moore, 1913). Oskar Fischer, a contemporary of Alzheimer and also a psychiatrist and
neuropathologist, also suggested that microorganisms could form plaques in brain tissues
(Fischer, 1907). Sporadic late-onset AD, accounting for ∼95–98% of all cases of AD is
thought to arise due to a multi-factorial interplay between genetic and environmental
factors. Linkage has been identified to risk factors including ApoEε4 expression, chronic
neuroinflammation, autoimmune mechanisms, oxidative and mitochondrial damage,
cardiovascular factors, diabetes with insulin resistance, trauma to the blood brain
barrier and selectively vulnerable brain insult. Thus, infection actually may be the
overarching “unifying hypothesis” for sporadic late-onset AD, rather than other more
mainstream hypotheses.
This Research Topic represents the efforts of the scientific community to better
understand causative factors for sporadic late-onset AD, and lends itself to consider
multiple elements and mechanisms participating in the pathogenesis of AD.
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Among many factors that may drive the accumulation of
amyloid and tau in AD, infectious triggers are some of the
most significant and logical choices. In particular, the organisms
likely to be involved in AD are those that can evade host
immune defenses, gain entry to specific selectively vulnerable
regions of the brain, and establish chronic/persistent and/or
latent infection. Early studies of infection did not find in
AD brains the direct evidence of viral nucleic acid sequences
and antigens of cytomegalovirus, measles virus, poliovirus,
adenoviruses, hepatitis B virus, and the influenza A and B viruses
(Pogo et al., 1987), although other authors have shown the
presence of HSV-1 (Ball, 1982; Itzhaki et al., 1997), Borrelia
burgdorferi (Miklossy, 1993), and Chlamydia pneumoniae (Balin
et al., 1998; Gerard et al., 2006) in AD brains. Besides that,
over the years the hypothesis on the possible role of HSV1 in AD has been supported by several in vitro studies,
suggesting that HSV-1 infection and its multiple reactivation
can trigger oxidative damage and progressive accumulation of
neurotoxic products (Amyloid-beta and hyperphosphorylated
Tau aggregates), leading to neurodegeneration and cognitive
decline (see: Marcocci et al., 2020). Moreover, host immunity
and its decline with aging can have an effect on the control
of HSV-1 viral reactivation from latency. Epidemiological
studies of the IgG avidity index as an indicator of HSV1 reactivation and the relationships between HSV-1-specific
humoral immunity and cortical damage measured by MRI, even
in relation with the host genetic pattern (see: Mancuso et al.,
2019), allow one to hypothesize the possible protective role of
antiviral IgG, although it remains to be confirmed by others.
Moreover, in the last twenty years, other different types
of infections have been associated with dementing illnesses,
including infection with Treponema pallidum (Miklossi, 2011),
as well as Cryptococcus neoformans (Hoffmann et al., 2009),
measles virus (Frings et al., 2002), and HIV (Zhou et al., 2010;
Canet et al., 2018). More recently, several studies have correlated
SARs-CoV2 virus in furthering the pathogenesis of AD (Fu et al.,
2022). Intriguingly, the involvement of the microbiota in AD
pathophysiology has also been gaining attention, as it may be
a key factor influencing brain function; intestinal microbiota
seems to interfere with Abeta assembly in brain (Wang et al.,
2015), but even oral microbiota can play a role in onset and
progression of AD (Sureda et al., 2020).
Local periodontal inflammation due to infection with
Helicobacter pylori (Beydoun et al., 2021), the agent of gastric
ulcers, or with Porphyromonas gingivalis (Elwishahy et al.,
2021), in fact, can stimulate brain tissue inflammation (Dominy
et al., 2019). Moreover, Wu et al. provided evidence in vitro
that Fusobacterium nucleatum can increased TNF-α and IL1β expression in microglial cells, and also in vivo it can
increase cognitive impairment, beta-amyloid accumulation and
Tau protein phosphorylation in the cerebrum of an AD
animal model.
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The impact of systemic acute infections on
neurodegeneration has been previously evaluated in animal
models of chronic neurodegeneration (Cunningham et al.,
2009), but only limited data exist on humans. The study of Silva
et al. analyzed the neuroinflammatory response triggered by
acute systemic inflammation in older subjects with dementia
compared to cognitively healthy controls. Using PET imaging,
the authors showed that the level of neuroinflammation due
to acute systemic infection was reduced in subjects with
dementia and/or delirium compared to cognitively healthy
participants. Future investigations are warranted to confirm
these observations, in order to clarify if “dementia” with changes
in brain has a distinct neuroinflammatory profile possibly owing
to immunosuppression within the brain in response to acute
systemic infection.
Lei et al. conducted a systematic review and meta-analysis to
determine the relationship between sepsis survivals and risk of
dementia in elderly individuals. They determined that there was
an increased risk of all-cause dementia in sepsis survival subjects
suggesting the importance of an appropriate management and
prevention scheme to preserve cognitive function.
Finally, Nelson explored the hypothesis that infections can
contribute to AD through the generation of peripheral amyloids
and/or neurovascular dysfunction. After a careful analysis of
available data supporting the neurovascular dysfunction and
blood-brain barrier permeability in AD, the author proposes in
this interesting review a new “peripheral amyloid hypothesis” as
a possible actor leading to cognitive impairment.
In summary, we are very grateful to the researchers that
contributed with an article as well the reviewers who have
contributed with their reviews to the quality of this Research
Topic. Overall, this Research Topic and the entire contribution
of literature to this hypothesis enables us to consider how
infections, and consequently the host immune response, may
play a significant role in the etiology of AD. We contend that
consideration of infection and subsequent inflammation in the
pathogenesis of AD may provide new avenues for intervention
to both delay progression and, ultimately, prevent disease.
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